期刊文献+

赫赛汀治疗HER-2高表达晚期乳腺癌的观察和护理 被引量:7

下载PDF
导出
摘要 总结8例晚期乳腺癌患者应用赫赛汀治疗的护理,加强健康教育,严格遵守操作规程,注意用药观察,是患者顺利完成整个治疗过程的重要保障。
作者 李娜 汪洋
出处 《天津护理》 2010年第1期13-14,共2页 Tianjin Journal of Nursing
  • 相关文献

参考文献4

  • 1Banning M. Advanced breast cancer: aetiology, treatment and psychosocial features[J]. British Journal Of Nursing,2007,16 (2) :86--90.
  • 2Moore S. Targeting metastatic and advanced breast cancer [J]. Seminars In Ontology Nursing, 2007,23 ( 1 ) : 37 -- 45.
  • 3孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2008:371.
  • 4王莉萍,沈坤炜,沈镇宙.赫赛汀在乳腺癌新辅助治疗与辅助治疗中的新进展[J].中华肿瘤杂志,2006,28(4):241-243. 被引量:26

二级参考文献9

  • 1Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med, 2001,344:783-792.
  • 2Cook-Bruns N. Retrospective analysis of the safety of Hereeptin immunotherapy in metastatic breast cancer. Oncology, 2001,61:S58-S66.
  • 3Pietras RJ, Pegram MD, Finn RS, et al. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs. Oncogene, 1998, 17:2235-2249.
  • 4Burstein HJ, Harris LN, Gelman R, et al. Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage Ⅱ or Ⅲ breast cancer: a pilot study. J Clin Oncol, 2003, 21:46-53.
  • 5Van Pelt AE, Mohsin S, Elledge RM, et al. Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results. Clin Breast Cancer, 2003, 4:348-353.
  • 6Schiffhauer LM, Griggs JJ, Ahrendt GM, et al. Docetaxd and trastuzumab as primary systemic therapy for HER-2/neu-overexpressing breast cancer. Proc Am Soc Clin Oncol, 2003, 22:242.
  • 7Hurley J, Doliny P, Silva O, et al. Neoadjuvant Hereeptin/taxotere/cisplatin in the treatment of locally advanced and inflammatory breast cancer., P roc AmSoc Clin Oncol, 2002, 21:50a.
  • 8Jahanzeb M, Brufsky A, Erban J, et al.Dose-dense neoadjuvant treatment of women with breast cancer utilizing docetaxel, vinorelbineand trastuzumab with growth factor support. J Clin Oncol, 2005,23:S591.
  • 9Baselga J, Gianni L, Geyer C, et al. Future options with trastuzumab for primary systemic and adjuvant therapy. Semin Oncol, 2004, 31 :S51-S57.

共引文献140

同被引文献21

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部